CATAlyst I Dr David Wiseman reveals why urgent review of C19 vaccines is critical + recommendations

In this must watch edition of CATalyst, Dr David Wiseman (

PhD Research Bioscientist who was one of the top research scientists at Johnson & Johnson) joins Shabnam Palesa Mohamed for a riveting discussion on US VAERS (Vaccine Adverse Events Reporting System) data that the public has a right to know about. During this informative and often shocking interview, we unpack the second expert letter written to the ACIP (Advisory Committee on Immunisation Practices) by Dr Wiseman and Dr Jessica Rose, Dr Josh Guetzkow and Dr Hervé Seligmann. This urgent letter raises critical issues on vaccine safety, and transparency concerns with regards to ACIP meetings:“Given the circumstances of how the December 16 meeting was announced, concerns about opacity are deepened. Like before, the late notice, the late-publication of a docket number, the failure of email notifications, and late posting of presentation slides, require corrective action.”

In the second letter to ACIP by these experts, the data-driven views on the vaccines include:

a) Contraindications are warranted for all quasi-vaccines, to include other events (thrombosis, myocarditis, etc.).

b) Focusing on a small subset of events in one quasi-vaccine is regulatory misdirection.

c) There is insufficient guidance on coagulopathies for Janssen and other quasi-vaccines.

d) COVID-19 quasi-vaccine in children 5-11 years: Urgent contraindication and re-evaluation of use is warranted.

e) ACIP should be discussing ever reduced benefit for greater risk of the quasi-vaccine rollout.

f) Attempting to boost our way out of new variants is the immunological equivalent of heroin addiction.

g) A full review of the existing EUAs and BLA is warranted - due to greater prevalence of adverse effects, as well as death far exceeding the TTS rate for Janssen, and the death reports for all three Covid-19 quasi-vaccines.

Dr Wiseman asks: Why aren't the regulators doing anything about the data being presented? He also answers questions on regulatory misdirection, whether what is going on is scientific fraud, and what a full review of the quasi-vaccines would look like. We also talk about the importance of ethical scientists and industry whistleblowers. Finally, he offers advice to the public about engaging with science to make informed decisions, and going to law makers and media to make your voice heard.